79% of Canadians favor end-of-life psilocybin therapy.
Almost 80% of Canadians accept psilocybin as a medical approach for existential distress in serious, incurable illnesses.
Stay updated with breaking news from Laval Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Almost 80% of Canadians accept psilocybin as a medical approach for existential distress in serious, incurable illnesses.
Nearly 4 out of 5 Canadians believe that the use of psilocybin, the active ingredient in hallucinogenic mushrooms, is an acceptable medical approach to treat ex
A new procedure developed in Quebec could enable women who have had a Caesarean birth to make a more informed decision about their next delivery.
A new program at the MUHC targets the unique needs of this "lost tribe" — an underserved population in oncology — to make sure they don’t fall between the cracks.
A large-scale international collaborative study lead by Professor Jacques Simard from Université Laval and Professor Douglas Easton at the University of Cambridge, UK, has identified new genes associated with breast cancer that could eventually be included in tests to identify women at increased risk.